Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

Asthma is a complex disorder frequently associated with a poor symptom control, concomitant morbidity, mortality, and significant health care costs due to lack of compliance or inadequate therapeutic options. Interleukin-5 (IL-5) plays a key role in the pathogenesis of eosinophilic disorders, and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzella, Francesco, Lusuardi, Mirco, Galeone, Carla, Taddei, Sofia, Zucchi, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603708/
https://www.ncbi.nlm.nih.gov/pubmed/26504401
http://dx.doi.org/10.2147/JAA.S40244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603708/
https://www.ncbi.nlm.nih.gov/pubmed/26504401
http://dx.doi.org/10.2147/JAA.S40244

Ejemplares similares